Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 204

    1.

    A polymorphic variant of the insulin-like growth factor type I receptor gene modifies risk of obesity for esophageal adenocarcinoma.

    MacDonald K, Porter GA, Guernsey DL, Zhao R, Casson AG.

    Cancer Epidemiol. 2009 Jul;33(1):37-40. Epub 2009 May 28.PMID: 19679045 [PubMed - indexed for MEDLINE]Related articles

    2.

    A phase II experience with neoadjuvant irinotecan (CPT-11), 5-fluorouracil (5-FU) and leucovorin (LV) for colorectal liver metastases.

    Bathe OF, Ernst S, Sutherland FR, Dixon E, Butts C, Bigam D, Holland D, Porter GA, Koppel J, Dowden S.

    BMC Cancer. 2009 May 20;9:156.PMID: 19457245 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Novel sorbents for removal of gadolinium-based contrast agents in sorbent dialysis and hemoperfusion: preventive approaches to nephrogenic systemic fibrosis.

    Yantasee W, Fryxell GE, Porter GA, Pattamakomsan K, Sukwarotwat V, Chouyyok W, Koonsiripaiboon V, Xu J, Raymond KN.

    Nanomedicine. 2009 May 15. [Epub ahead of print]PMID: 19447204 [PubMed - as supplied by publisher]Related articles

    4.

    Regulation of CDX2 expression in esophageal adenocarcinoma.

    Vaninetti N, Williams L, Geldenhuys L, Porter GA, Guernsey DL, Casson AG.

    Mol Carcinog. 2009 Oct;48(10):965-74.PMID: 19415720 [PubMed - indexed for MEDLINE]Related articles

    5.

    Surgical site infections following colorectal surgery in patients with diabetes: association with postoperative hyperglycemia.

    McConnell YJ, Johnson PM, Porter GA.

    J Gastrointest Surg. 2009 Mar;13(3):508-15. Epub 2008 Nov 11.PMID: 19002535 [PubMed - indexed for MEDLINE]Related articles

    6.

    Inducible nitric oxide synthase, nitrotyrosine and p53 mutations in the molecular pathogenesis of Barrett's esophagus and esophageal adenocarcinoma.

    Vaninetti NM, Geldenhuys L, Porter GA, Risch H, Hainaut P, Guernsey DL, Casson AG.

    Mol Carcinog. 2008 Apr;47(4):275-85.PMID: 17849424 [PubMed - indexed for MEDLINE]Related articles

    7.

    Alternative splicing of the FGF antisense gene: differential subcellular localization in human tissues and esophageal adenocarcinoma.

    Zhang SC, Barclay C, Alexander LA, Geldenhuys L, Porter GA, Casson AG, Murphy PR.

    J Mol Med. 2007 Nov;85(11):1215-28. Epub 2007 Jun 14.PMID: 17569023 [PubMed - indexed for MEDLINE]Related articles

    8.

    Selective cyclooxygenase-2 inhibition suppresses basic fibroblast growth factor expression in human esophageal adenocarcinoma.

    Baguma-Nibasheka M, Barclay C, Li AW, Geldenhuys L, Porter GA, Blay J, Casson AG, Murphy PR.

    Mol Carcinog. 2007 Dec;46(12):971-80.PMID: 17477358 [PubMed - indexed for MEDLINE]Related articles

    9.

    Factors influencing waiting times for elective laparoscopic cholecystectomy.

    Lau R, Vair BA, Porter GA.

    Can J Surg. 2007 Feb;50(1):34-8.PMID: 17391614 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Emergency room presentation of colorectal cancer: a consecutive cohort study.

    Mitchell AD, Inglis KM, Murdoch JM, Porter GA.

    Ann Surg Oncol. 2007 Mar;14(3):1099-104. Epub 2007 Jan 9.PMID: 17211732 [PubMed - indexed for MEDLINE]Related articles

    11.

    Genetic polymorphisms of microsomal epoxide hydroxylase and glutathione S-transferases M1, T1 and P1, interactions with smoking, and risk for esophageal (Barrett) adenocarcinoma.

    Casson AG, Zheng Z, Porter GA, Guernsey DL.

    Cancer Detect Prev. 2006;30(5):423-31. Epub 2006 Oct 24.PMID: 17064856 [PubMed - indexed for MEDLINE]Related articles

    12.

    Obesity and lifestyle risk factors for gastroesophageal reflux disease, Barrett esophagus and esophageal adenocarcinoma.

    Veugelers PJ, Porter GA, Guernsey DL, Casson AG.

    Dis Esophagus. 2006;19(5):321-8.PMID: 16984526 [PubMed - indexed for MEDLINE]Related articles

    13.

    Increasing negative lymph node count is independently associated with improved long-term survival in stage IIIB and IIIC colon cancer.

    Johnson PM, Porter GA, Ricciardi R, Baxter NN.

    J Clin Oncol. 2006 Aug 1;24(22):3570-5.PMID: 16877723 [PubMed - indexed for MEDLINE]Related articles

    14.

    Non-contrast-enhanced computerized tomography and analgesic-related kidney disease: report of the national analgesic nephropathy study.

    Henrich WL, Clark RL, Kelly JP, Buckalew VM, Fenves A, Finn WF, Shapiro JI, Kimmel PL, Eggers P, Agodoa LE, Porter GA, Shapiro S, Toto R, Anderson T, Cupples LA, Kaufman DW.

    J Am Soc Nephrol. 2006 May;17(5):1472-80. Epub 2006 Apr 12.PMID: 16611714 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Retroperitoneal sarcoma: a population-based analysis of epidemiology, surgery, and radiotherapy.

    Porter GA, Baxter NN, Pisters PW.

    Cancer. 2006 Apr 1;106(7):1610-6.PMID: 16518798 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Effect of obesity on presentation of breast cancer.

    Porter GA, Inglis KM, Wood LA, Veugelers PJ.

    Ann Surg Oncol. 2006 Mar;13(3):327-32. Epub 2006 Jan 30.PMID: 16485153 [PubMed - indexed for MEDLINE]Related articles

    17.

    Caspases 3 and 7: key mediators of mitochondrial events of apoptosis.

    Lakhani SA, Masud A, Kuida K, Porter GA Jr, Booth CJ, Mehal WZ, Inayat I, Flavell RA.

    Science. 2006 Feb 10;311(5762):847-51.PMID: 16469926 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Basic fibroblast growth factor (FGF-2) overexpression is a risk factor for esophageal cancer recurrence and reduced survival, which is ameliorated by coexpression of the FGF-2 antisense gene.

    Barclay C, Li AW, Geldenhuys L, Baguma-Nibasheka M, Porter GA, Veugelers PJ, Murphy PR, Casson AG.

    Clin Cancer Res. 2005 Nov 1;11(21):7683-91.PMID: 16278388 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Access to care and satisfaction in colorectal cancer patients.

    Porter GA, Inglis KM, Wood LA, Veugelers PJ.

    World J Surg. 2005 Nov;29(11):1444-51.PMID: 16240060 [PubMed - indexed for MEDLINE]Related articles

    20.

    Cyclin D1 polymorphism (G870A) and risk for esophageal adenocarcinoma.

    Casson AG, Zheng Z, Evans SC, Geldenhuys L, van Zanten SV, Veugelers PJ, Porter GA, Guernsey DL.

    Cancer. 2005 Aug 15;104(4):730-9.PMID: 15971196 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    Ten years of breast screening in the Nova Scotia Breast Screening Program, 1991-2001. experience: use of an adaptable stereotactic device in the diagnosis of screening-detected abnormalities.

    Caines JS, Schaller GH, Iles SE, Woods ER, Barnes PJ, Johnson AJ, Jones GR, Borgaonkar JN, Rowe JA, Topp TJ, Porter GA.

    Can Assoc Radiol J. 2005 Apr;56(2):82-93.PMID: 15957275 [PubMed - indexed for MEDLINE]Related articles

    22.

    Polymorphisms in DNA repair genes in the molecular pathogenesis of esophageal (Barrett) adenocarcinoma.

    Casson AG, Zheng Z, Evans SC, Veugelers PJ, Porter GA, Guernsey DL.

    Carcinogenesis. 2005 Sep;26(9):1536-41. Epub 2005 May 5.PMID: 15878910 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Ductal carcinoma in situ in core biopsies containing invasive breast cancer: correlation with extensive intraductal component and lumpectomy margins.

    Dzierzanowski M, Melville KA, Barnes PJ, MacIntosh RF, Caines JS, Porter GA.

    J Surg Oncol. 2005 May 1;90(2):71-6.PMID: 15844190 [PubMed - indexed for MEDLINE]Related articles

    24.

    An unusual presentation of a secondary extramedullary plasmacytoma in a patient with multiple myeloma.

    Dzierzanowski M, Porter GA.

    Can J Surg. 2005 Feb;48(1):75-6. No abstract available. PMID: 15757045 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    Microsatellite instability in esophageal adenocarcinoma.

    Evans SC, Gillis A, Geldenhuys L, Vaninetti NM, Malatjalian DA, Porter GA, Guernsey DL, Casson AG.

    Cancer Lett. 2004 Aug 30;212(2):241-51.PMID: 15279904 [PubMed - indexed for MEDLINE]Related articles

    26.

    Cost-effectiveness of pulmonary resection and systemic chemotherapy in the management of metastatic soft tissue sarcoma: a combined analysis from the University of Texas M. D. Anderson and Memorial Sloan-Kettering Cancer Centers.

    Porter GA, Cantor SB, Walsh GL, Rusch VW, Leung DH, DeJesus AY, Pollock RE, Brennan MF, Pisters PW.

    J Thorac Cardiovasc Surg. 2004 May;127(5):1366-72.PMID: 15115994 [PubMed - indexed for MEDLINE]Related articles

    27.

    Right coronary artery arising from the left ventricular outflow tract: a rare congenital anomaly of the coronary arteries.

    Moltedo JM, Kopf G, Mello DM, Porter GA Jr.

    Pediatr Cardiol. 2003 Nov-Dec;24(6):598-600. No abstract available. PMID: 14761156 [PubMed - indexed for MEDLINE]Related articles

    28.

    Practice patterns in breast cancer surgery: Canadian perspective.

    Porter GA, McMulkin-Tait H.

    World J Surg. 2004 Jan;28(1):80-6. Epub 2003 Nov 26.PMID: 14639490 [PubMed - indexed for MEDLINE]Related articles

    29.

    Emerging patterns of practice in the implementation and application of sentinel lymph node biopsy in breast cancer patients in Canada.

    Porter GA.

    J Surg Oncol. 2003 Jun;83(2):62-4. No abstract available. PMID: 12772196 [PubMed - indexed for MEDLINE]Related articles

    30.

    Clinical implications of p53 tumor suppressor gene mutation and protein expression in esophageal adenocarcinomas: results of a ten-year prospective study.

    Casson AG, Evans SC, Gillis A, Porter GA, Veugelers P, Darnton SJ, Guernsey DL, Hainaut P.

    J Thorac Cardiovasc Surg. 2003 May;125(5):1121-31.PMID: 12771886 [PubMed - indexed for MEDLINE]Related articles

    31.

    Intracellular calcium plays an essential role in cardiac development.

    Porter GA Jr, Makuck RF, Rivkees SA.

    Dev Dyn. 2003 Jun;227(2):280-90.PMID: 12761855 [PubMed - indexed for MEDLINE]Related articlesFree article

    32.

    Sentinel lymph node biopsy in breast cancer: Canadian practice patterns.

    Porter GA, McMulkin H, Lovrics PJ.

    Ann Surg Oncol. 2003 Apr;10(3):255-60.PMID: 12679310 [PubMed - indexed for MEDLINE]Related articles

    33.

    Relationship between elevated serum troponin values in end-stage renal disease patients and abnormal isotopic cardiac scans following stress.

    Porter GA, Norton TL, Lindsley J, Stevens JS, Phillips DS, Bennett WM.

    Ren Fail. 2003 Jan;25(1):55-65.PMID: 12617333 [PubMed - indexed for MEDLINE]Related articles

    34.

    Adequacy of nodal harvest in colorectal cancer: a consecutive cohort study.

    Johnson PM, Malatjalian D, Porter GA.

    J Gastrointest Surg. 2002 Nov-Dec;6(6):883-88; discussion 889-90.PMID: 12504228 [PubMed - indexed for MEDLINE]Related articles

    35.

    Evolution and critical appraisal of anastomotic technique following resection of esophageal adenocarcinoma.

    Casson AG, Porter GA, Veugelers PJ.

    Dis Esophagus. 2002;15(4):296-302.PMID: 12472475 [PubMed - indexed for MEDLINE]Related articles

    36.

    Sinus node dysfunction associated with lithium therapy in a child.

    Moltedo JM, Porter GA, State MW, Snyder CS.

    Tex Heart Inst J. 2002;29(3):200-2.PMID: 12224723 [PubMed - indexed for MEDLINE]Related articlesFree article

    37.

    Presence of the human leukocyte antigen class II gene DRB1*1101 predicts interferon gamma levels and disease recurrence in melanoma patients.

    Lee JE, Abdalla J, Porter GA, Bradford L, Grimm EA, Reveille JD, Mansfield PF, Gershenwald JE, Ross MI.

    Ann Surg Oncol. 2002 Jul;9(6):587-93.PMID: 12095976 [PubMed - indexed for MEDLINE]Related articles

    38.

    Reduction in intracellular calcium levels inhibits myoblast differentiation.

    Porter GA Jr, Makuck RF, Rivkees SA.

    J Biol Chem. 2002 Aug 9;277(32):28942-7. Epub 2002 May 31.PMID: 12042317 [PubMed - indexed for MEDLINE]Related articlesFree article

    39.

    Hepatitis B or C virus serology as a prognostic factor in patients with hepatocellular carcinoma.

    Ahmad SA, Bilimoria MM, Wang X, Izzo F, Delrio P, Marra P, Baker TP, Porter GA, Ellis LM, Vauthey JN, Dhamotharan S, Curley SA.

    J Gastrointest Surg. 2001 Sep-Oct;5(5):468-76.PMID: 11985997 [PubMed - indexed for MEDLINE]Related articles

    40.

    Cost-effectiveness of staging computed tomography of the chest in patients with T2 soft tissue sarcomas.

    Porter GA, Cantor SB, Ahmad SA, Lenert JT, Ballo MT, Hunt KK, Feig BW, Patel SR, Benjamin RS, Pollock RE, Pisters PW.

    Cancer. 2002 Jan 1;94(1):197-204.PMID: 11815977 [PubMed - indexed for MEDLINE]Related articlesFree article

    41.

    Ontogeny of humoral heart rate regulation in the embryonic mouse.

    Porter GA Jr, Rivkees SA.

    Am J Physiol Regul Integr Comp Physiol. 2001 Aug;281(2):R401-7.PMID: 11448841 [PubMed - indexed for MEDLINE]Related articles

    42.

    Significance of plasma cytokine levels in melanoma patients with histologically negative sentinel lymph nodes.

    Porter GA, Abdalla J, Lu M, Smith S, Montgomery D, Grimm E, Ross MI, Mansfield PF, Gershenwald JE, Lee JE.

    Ann Surg Oncol. 2001 Mar;8(2):116-22.PMID: 11258775 [PubMed - indexed for MEDLINE]Related articles

    43.

    Limitations of size as a criterion in the evaluation of adrenal tumors.

    Barnett CC Jr, Varma DG, El-Naggar AK, Dackiw AP, Porter GA, Pearson AS, Kudelka AP, Gagel RF, Evans DB, Lee JE.

    Surgery. 2000 Dec;128(6):973-82;discussion 982-3.PMID: 11114632 [PubMed - indexed for MEDLINE]Related articles

    44.

    Long term follow up of the utility of troponin T to assess cardiac risk in stable chronic hemodialysis patients.

    Porter GA, Norton T, Bennett WM.

    Clin Lab. 2000;46(9-10):469-76.PMID: 11034532 [PubMed - indexed for MEDLINE]Related articles

    45.

    Cost and utilization impact of a clinical pathway for patients undergoing pancreaticoduodenectomy.

    Porter GA, Pisters PW, Mansyur C, Bisanz A, Reyna K, Stanford P, Lee JE, Evans DB.

    Ann Surg Oncol. 2000 Aug;7(7):484-9.PMID: 10947015 [PubMed - indexed for MEDLINE]Related articles

    46.

    How many lymph nodes are enough during sentinel lymphadenectomy for primary melanoma?

    Porter GA, Ross MI, Berman RS, Sumner WE 3rd, Lee JE, Mansfield PF, Gershenwald JE.

    Surgery. 2000 Aug;128(2):306-11.PMID: 10923009 [PubMed - indexed for MEDLINE]Related articles

    47.

    Outcomes research in surgical oncology.

    Porter GA, Skibber JM.

    Ann Surg Oncol. 2000 Jun;7(5):367-75. Review.PMID: 10864345 [PubMed - indexed for MEDLINE]Related articles

    48.

    Significance of multiple nodal basin drainage in truncal melanoma patients undergoing sentinel lymph node biopsy.

    Porter GA, Ross MI, Berman RS, Lee JE, Mansfield PF, Gershenwald JE.

    Ann Surg Oncol. 2000 May;7(4):256-61.PMID: 10819364 [PubMed - indexed for MEDLINE]Related articles

    49.

    Laparoscopic splenectomy in patients with hematologic malignancies.

    Berman RS, Yahanda AM, Mansfield PF, Hemmila MR, Sweeney JF, Porter GA, Kumparatana M, Leroux B, Pollock RE, Feig BW.

    Am J Surg. 1999 Dec;178(6):530-6.PMID: 10670866 [PubMed - indexed for MEDLINE]Related articles

    50.

    Urinary biomarkers: recommendations of the Joint European/United States Workshop for future research.

    Finn WF, Porter GA.

    Ren Fail. 1999 May-Jul;21(3-4):445-51. Review.PMID: 10416225 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...